U.S. Markets open in 5 hrs 44 mins

Bristol-Myers CEO: Celgene merger will yield 6 products in 24 months

Jim Cramer interviews Bristol-Myers Squibb CEO Giovanni Caforio to learn about the company's $74 billion bid for Celgene.